Post by GBA Group Pharma

Thank you for the inspiring discussions at ESTIV 2026! ESTIV 2026 provides an excellent opportunity to present our scientific poster on assessing the human relevance of thyroid disruption using New Approach Methodologies (NAMs), position #169. We truly appreciate the valuable discussions and the strong interest in our integrated in vitro approach to better understand the multiple mechanisms that may influence thyroid hormone homeostasis. A sincere thank you to everyone who visit our poster and share their perspectives. Scientific exchange plays a key role in advancing modern testing strategies and improving human-relevant risk assessment. We also invite you to look at the PEPPER poster regarding Transthyretin (TTR) validation data. As KaLy-Cell was involved as a naive lab, we can address any questions you may have on this new assay. GBA Group – Know what's inside. #ESTIV2026 #NAMs #Toxicology #Endocrine disruption #KaLyCell #GBAPharma